Skip to main content
. 2016 Oct 4;7(43):69276–69290. doi: 10.18632/oncotarget.12472

Figure 1. Changes of liver function (mean ±SD) before and after terlipressin treatment in ESLD patients.

Figure 1

Enrolled patients with ESLD were treated with terlipressin (1-2 mg/day) for 3-7 days. Individual values of serum ALT, AST, TBIL and ALB were measured. *p < 0.05. ALT, alanine transaminase; AST, aspartate aminotransferase; TBIL, total bilirubin; ALB, albumin.